Search Results - Paul N. Mainwaring

Refine Results
  1. 1
    A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy

    A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy by Junrong Li, Alain Wuethrich, Abu Ali Ibn Sina, Han‐Hao Cheng, Yuling Wang, Andreas Behren, Paul N. Mainwaring, Matt Trau

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer

    Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer by Alberto Sobrero, Stephen P. Ackland, Stephen Clarke, R. Pérez-Carrión, Silvia Chiara, J. Gapski, Paul N. Mainwaring, Bernd Langer, Scott Young

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results

    Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results by Simon J. Harrison, Paul N. Mainwaring, Timothy Price, Michael Millward, Peeter Padrik, Craig Underhill, Paul Cannell, Steven D. Reich, Mohit Trikha, Andrew Spencer

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy

    Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy by Cora N. Sternberg, A. Molina, Scott North, Paul N. Mainwaring, Karim Fizazi, Yanni Hao, Margaret Rothman, Dennis D. Gagnon, Thian Kheoh, C. Haqq, Charles S. Cleeland, Johann S. de Bono, Howard I. Scher

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)

    Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON I... by Hans‐Joachim Schmoll, David Cunningham, Alberto Sobrero, Christos S. Karapetis, Philippe Rougier, Sheryl Koski, Ilona Kocáková, Igor Bondarenko, G. Bodoky, Paul N. Mainwaring, Ramón Salazar, Peter Barker, Bijoyesh Mookerjee, Jane Robertson, Eric Van Cutsem

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial

    Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-control... by Fred Saad, David Cella, Ethan Basch, Boris Hadaschik, Paul N. Mainwaring, Stéphane Oudard, Julie N. Graff, Kelly McQuarrie, Susan Li, Stacie Hudgens, Joe Lawson, Angela Lopez‐Gitlitz, Margaret K. Yu, Matthew R. Smith, Eric J. Small

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer

    Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer by Eric J. Small, Fred Saad, S. Chowdhury, Stéphane Oudard, Boris Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, J.Y. Lee, Hiroji Uemura, Peter De Porre, Alexis K. Smith, K. Zhang, Angela Lopez‐Gitlitz, Matthew R. Smith

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer

    CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients... by E. Gabriela Chiorean, Daniel D. Von Hoff, Michele Reni, Francis P. Arena, Jeffrey R. Infante, V. Bathini, Tina E. Wood, Paul N. Mainwaring, Robert T. Muldoon, P. Clingan, Volker Kunzmann, Ramesh K. Ramanathan, Josep Tabernero, David Goldstein, D. McGovern, Brian Lu, Andrew H. Ko

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Apalutamide and Overall Survival in Prostate Cancer

    Apalutamide and Overall Survival in Prostate Cancer by Matthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, Ji Youl Lee, Hiroji Uemura, Peter De Porre, Alexis K. Smith, Sabine Brookman‐May, Susan Li, Ke Zhang, Brendan Rooney, Angela Lopez‐Gitlitz, Eric J. Small

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

    Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer by Matthew R. Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris Hadaschik, Julie N. Graff, David Olmos, Paul N. Mainwaring, Ji Youl Lee, Hiroji Uemura, Angela Lopez‐Gitlitz, Géralyn C. Trudel, Byron M. Espina, Youyi Shu, Youn C. Park, Wayne Rackoff, Margaret K. Yu, Eric J. Small

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients

    First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients by Ian E. Smith, Jean‐Yves Pierga, Laura Biganzoli, H. Cortés-Funes, Christoph Thomssen, Xavier Pivot, Alessandra Fabi, Binghe Xu, Daniil Stroyakovskiy, Fábio Franke, Bella Kaufman, Paul N. Mainwaring, Tadeusz Pieńkowski, B. De Valk, Ava Kwong, José Luis González-Trujillo, I Koza, Katarína Petráková, Deolinda Pereira, K.I. Pritchard

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy by Howard I. Scher, Karim Fizazi, Fred Saad, Mary‐Ellen Taplin, Cora N. Sternberg, Kurt Miller, Ronald de Wit, Peter F.A. Mulders, Kim N., Neal D. Shore, Andrew J. Armstrong, Thomas W. Flaig, Aude Fléchon, Paul N. Mainwaring, Mark T. Fleming, John D. Hainsworth, Mohammad Hirmand, Bryan Selby, Lynn Seely, Johann S. de Bono

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

    Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma by Martin Gore, Cezary Szczylik, Camillo Porta, Sergio Bracarda, Georg A. Bjarnason, Stéphane Oudard, SH Lee, John B.A.G. Haanen, Daniel Castellano, Eduard Vrdoljak, Patrick Schöffski, Paul N. Mainwaring, Robert E. Hawkins, Lucio Crinò, Tae Min Kim, Giacomo Cartenì, Wilfried Eberhardt, Kai Zhang, K. Fly, Ewa Matczak, M.J. Lechuga, Seetharaman Hariharan, Ronald M. Bukowski

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial

    Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial by David Cella, Bernard Escudier, Nizar M. Tannir, Thomas Powles, Frede Donskov, Katriina Peltola, Manuela Schmidinger, Daniel Y.C. Heng, Paul N. Mainwaring, Hans J. Hammers, Jae‐Lyun Lee, Bruce J. Roth, Florence Marteau, Paul Williams, John E. Baer, Milan Mangeshkar, Christian Scheffold, Thomas E. Hutson, Sumanta K. Pal, Robert J. Motzer, Toni K. Choueiri

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302

    Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA... by Fred Saad, Neal D. Shore, Hendrik Van Poppel, Dana E. Rathkopf, Matthew R. Smith, Johann S. de Bono, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Peter F.A. Mulders, Paul N. Mainwaring, John D. Hainsworth, Tomasz M. Beer, Scott North, Yves Fradet, Thomas A. Griffin, Peter De Porre, Anil Londhe, Thian Kheoh, Eric J. Small, Howard I. Scher, Arturo Molina, Charles J. Ryan

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

    Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma by Toni K. Choueiri, Bernard Escudier, Thomas Powles, Paul N. Mainwaring, Brian I. Rini, Frede Donskov, Hans J. Hammers, Thomas E. Hutson, Jae‐Lyun Lee, Katriina Peltola, Bruce J. Roth, Georg A. Bjarnason, Lajos Géczi, Bhumsuk Keam, Pablo Maroto, Daniel Y.C. Heng, Manuela Schmidinger, Philip W. Kantoff, Anne E. Borgman-Hagey, Colin Hessel, Christian Scheffold, Gisela Schwab, Nizar M. Tannir, Robert J. Motzer

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor–Positive Breast Cancer

    Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor–Po... by Peter Schmid, Sarah E. Pinder, Duncan Wheatley, Jane Macaskill, Charles Zammit, Jennifer J. Hu, R. Jordan Price, Nigel Bundred, Sirwan Hadad, Alice Shia, Shah-Jalal Sarker, Louise Lim, Patrycja Gazińska, Natalie Woodman, Darren Korbie, Matt Trau, Paul N. Mainwaring, Steven Gendreau, Mark R. Lackner, Mika K. Derynck, Timothy R. Wilson, H. EUGENE BUTLER, Gemma Earl, Peter J. Parker, Arnie Purushotham, Alastair M. Thompson

    Published 2016
    Get full text
    Carta
    Save to List
    Saved in:
  18. 18
    Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

    Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1 by Matthew R. Smith, Johann S. de Bono, Cora N. Sternberg, Sylvestre Le Moulec, Stéphane Oudard, Ugo De Giorgi, Michael Krainer, Andries M. Bergman, Wolfgang Hoelzer, Ronald de Wit, Martin Bögemann, Fred Saad, Giorgio Cruciani, Antoine Thiery-Vuillemin, Susan Feyerabend, Kurt Miller, Nadine Houédé, Syed A. Hussain, Elaine T. Lam, Jonathan Polikoff, Arnulf Stenzl, Paul N. Mainwaring, David A. Ramies, Colin Hessel, Aaron Weitzman, Karim Fizazi

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

    Enzalutamide in Metastatic Prostate Cancer before Chemotherapy by Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano, Peter Iversen, Suman Bhattacharya, Joan Carles, Simon Chowdhury, Ian D. Davis, Johann S. de Bono, Christopher P. Evans, Karim Fizazi, Anthony M. Joshua, Choung‐Soo Kim, Go Kimura, Paul N. Mainwaring, Harry H. Mansbach, Kurt Miller, Sarah B. Noonberg, Frank Perabo, De Phung, Fred Saad, Howard I. Scher, Mary‐Ellen Taplin, Peter Venner, Bertrand Tombal

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Abiraterone and Increased Survival in Metastatic Prostate Cancer

    Abiraterone and Increased Survival in Metastatic Prostate Cancer by Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N., Robert J. Jones, Oscar B. Goodman, Fred Saad, John Staffurth, Paul N. Mainwaring, Stephen Harland, Thomas W. Flaig, Thomas E. Hutson, Tina Cheng, Helen Patterson, John D. Hainsworth, Charles J. Ryan, Cora N. Sternberg, Susan Ellard, Aude Fléchon, Mansoor N. Saleh, Mark C. Scholz, Eleni Efstathiou, Andrea Zivi, Diletta Bianchini, Yohann Loriot, Nicole Chieffo, Thian Kheoh, Christopher M. Haqq, Howard I. Scher

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: